Report Phase 2 proof-of-concept data for Factor XIa inhibitor
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 11 Jan 2021
- Due
- 31 Dec 2022
- Delivered
- by 26 Aug 2022
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“FXIa-i + clopidogrel + aspirin vs. clopidogrel + aspirin Expected 2022”
What we found
Evidence strength A What the grades mean
The company reported Phase 2 proof-of-concept data for the Factor XIa inhibitor (milvexian) from the AXIOMATIC-SSP study at the European Society of Cardiology (ESC) Congress in August 2022.
-
A Bristol Myers Squibb Co. 8-K filed 2023-01-09
“AXIOMATIC-SSP Phase 2 data (ESC 2022) Compelling reduction in symptomatic ischemic strokes” ✓ confirmed on the page
Market reaction: the shares moved -3.4% against the S&P 500 over the three sessions around the disclosure (6 Jan 2023 to 11 Jan 2023). What this measures
Checked 2 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical readout
- Indicative materiality
- Medium rules
- Action
- Report
- Deliverable
- Phase 2 proof-of-concept data
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Bristol Myers Squibb Co.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-BMY-004000 · Corrections policy